Boehringer Hosts Equine Airway Disease CPD Meetings
8 years ago 
1843 views
Boehringer Ingelheim, manufacturer of Equisolon, Sputolosin and Ventipulmin, is hosting a series of seven complimentary equine airway disease CPD meetings around the country to give veterinary surgeons an opportunity to update their equine airway disease knowledge.
Presented by some of the country’s leading experts on equine respiratory disease, speakers include: Dr Scott Pirie from University of Edinburgh, David Rendle from Rainbow Equine Hospital, Dr Tim Brazil from Equine Medicine on the Move, Phil Ivens from Buckingham Equine Medicine Referrals and Prof. Andy Durham from the Liphook Equine Hospital.
The clinical lectures will cover content that should be immediately relevant to an equine vet’s respiratory caseload. In addition, there is a workshop entitled ‘The Influential Vet’, an unmissable interactive seminar that will help veterinary surgeons to improve their client relationships, increase their personal influence and manage difficult situations.
“We know that our customers like to feel fully equipped when dealing with RAO,” comments Clare Turnbull, equine brand and technical manager at Boehringer. “So we are delighted to be able to bring up to date, high quality and innovative equine CPD to our customers. The Influential Vet workshop will provide the soft skills that can help put this knowledge into practice; we hope our customers will leave feeling not just informed, but inspired too.”
The CPD meetings take place in: Hinckley, Leicestershire on Tuesday 16 February; Knutsford, Cheshire on Thursday 18 February; Chelmsford, Essex on Tuesday 23 February: Ripon, North Yorkshire on Thursday 24 February; Peebles, Scottish Borders on Wednesday 2 March; Hickstead, West Sussex on Tuesday 8 March and Bridgwater, Somerset on Thursday 10 March.
For further information and to register, visit www.equinecpd.co.uk/respiratory.
More from Boehringer Ingelheim
- Boehringer Ingelheim receives FDA approval for SENVELGO® (velagliflozin oral solution): the first oral liquid medication for diabetes in cats
- Boehringer Ingelheim Animal Health launches new ProZinc webinar and toolkit
- NexGard Spectra ‘Yum and Done’ competition winner announced
- Boehringer Ingelheim launches Parassess - a “first-of-its-kind”, online, personalised dog parasite risk checker
- ABCD & Boehringer Ingelheim invite applications for the 2022 Young Scientist Award
4 hours ago